A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

The US Food and Drug Administration (FDA) rejected three prior regulatory applications before granting approval.

Sanofi has joined a growing list of drugmakers going after alpha-synuclein targeting drugs for Parkinson's disease, licensing a bispecific antibody from South Korea's ABL Bio in a deal that could ...

Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But ...

We recently published a list of 7 Best Nanotech Penny Stocks to Invest In. In this article, we are going to take a look at ...

While patients with Parkinson’s initially start taking oral drugs like levodopa and carbidopa ... patients who cannot have apomorphine, with a list price of £84.70 per vial ahead of discounts.

Michael J. Fox might have a wholesome reputation these days, but he and a bunch of his celebrity friends once got busted by ...

Top supplements to boost focus and concentration - Find your focus with nootropics that help keep your mind clear ...

Acadia Pharmaceuticals' forecasted revenues top $1bn in 2025. Find out why ACAD stock is a "Buy" with its profitable outlook ...

It’s not a secret that sleep can get more difficult with age — research suggests that up to half of older adults complain of ...

A violinist plays for her father. A singer takes requests. In hospitals and hospices, bedside performers offer a new kind of ...